Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by d...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | LESCHE RALF NIMMRICH INKO LUKAS ANTJE KLUTH HARTMANN OLIVER MARX ALMUTH MAIER SABINE SCHWOPE INA |
description | Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2009269736A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2009269736A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2009269736A13</originalsourceid><addsrcrecordid>eNqNjcEKwjAQRHvxIOo_LHgWtYVKjyKKR0E9l5hsJJhmy-6a7zeCH-BpGHjzZlrlC9MzkWiwMBh-IQt4YhgZXbAaKAF5UEajAyYFRhkpCYJJbl04eXMO2cQv9SiUKFiMsewpBo9sNGQEF4TYYdGWXjQyrybeRMHFL2fV8nS8Hc4rHKkvF8ZiQu3v13qz6eq22zXtftv8R30A6T9Hyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><source>esp@cenet</source><creator>LESCHE RALF ; NIMMRICH INKO ; LUKAS ANTJE KLUTH ; HARTMANN OLIVER ; MARX ALMUTH ; MAIER SABINE ; SCHWOPE INA</creator><creatorcontrib>LESCHE RALF ; NIMMRICH INKO ; LUKAS ANTJE KLUTH ; HARTMANN OLIVER ; MARX ALMUTH ; MAIER SABINE ; SCHWOPE INA</creatorcontrib><description>Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091029&DB=EPODOC&CC=US&NR=2009269736A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091029&DB=EPODOC&CC=US&NR=2009269736A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LESCHE RALF</creatorcontrib><creatorcontrib>NIMMRICH INKO</creatorcontrib><creatorcontrib>LUKAS ANTJE KLUTH</creatorcontrib><creatorcontrib>HARTMANN OLIVER</creatorcontrib><creatorcontrib>MARX ALMUTH</creatorcontrib><creatorcontrib>MAIER SABINE</creatorcontrib><creatorcontrib>SCHWOPE INA</creatorcontrib><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><description>Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjcEKwjAQRHvxIOo_LHgWtYVKjyKKR0E9l5hsJJhmy-6a7zeCH-BpGHjzZlrlC9MzkWiwMBh-IQt4YhgZXbAaKAF5UEajAyYFRhkpCYJJbl04eXMO2cQv9SiUKFiMsewpBo9sNGQEF4TYYdGWXjQyrybeRMHFL2fV8nS8Hc4rHKkvF8ZiQu3v13qz6eq22zXtftv8R30A6T9Hyw</recordid><startdate>20091029</startdate><enddate>20091029</enddate><creator>LESCHE RALF</creator><creator>NIMMRICH INKO</creator><creator>LUKAS ANTJE KLUTH</creator><creator>HARTMANN OLIVER</creator><creator>MARX ALMUTH</creator><creator>MAIER SABINE</creator><creator>SCHWOPE INA</creator><scope>EVB</scope></search><sort><creationdate>20091029</creationdate><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><author>LESCHE RALF ; NIMMRICH INKO ; LUKAS ANTJE KLUTH ; HARTMANN OLIVER ; MARX ALMUTH ; MAIER SABINE ; SCHWOPE INA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2009269736A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LESCHE RALF</creatorcontrib><creatorcontrib>NIMMRICH INKO</creatorcontrib><creatorcontrib>LUKAS ANTJE KLUTH</creatorcontrib><creatorcontrib>HARTMANN OLIVER</creatorcontrib><creatorcontrib>MARX ALMUTH</creatorcontrib><creatorcontrib>MAIER SABINE</creatorcontrib><creatorcontrib>SCHWOPE INA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LESCHE RALF</au><au>NIMMRICH INKO</au><au>LUKAS ANTJE KLUTH</au><au>HARTMANN OLIVER</au><au>MARX ALMUTH</au><au>MAIER SABINE</au><au>SCHWOPE INA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><date>2009-10-29</date><risdate>2009</risdate><abstract>Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2009269736A1 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
title | Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A56%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LESCHE%20RALF&rft.date=2009-10-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2009269736A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |